Clinical Trial Update: Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial of tislelizumab with chemotherapy for microsatellite-stable colon cancer is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• Tislelizumab (tislelizumab)

Snippet

Sponsor: First Affiliated Hospital of Guangxi Medical University | Conditions: Colonic Neoplasms, Neoadjuvant Therapy | Phase 2 | Status: ACTIVE_NOT_RECRUITING